BTIG analyst Andre Madrid initiated coverage of BWX Technologies with a Buy rating and $110 price target. The firm expects the company to continue being one of the faster-growing defense subcontractors over the coming years and notes that while shares are already up about 23% year-to-date it believes there remains upside driven by potentially stronger margin from nuclear medicine and improving working capital management.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BWXT:
- BWX Technologies awarded second phase of contract with Wyoming Energy Authority
- Fluor team awarded NNSA’s Pantex plant management and operating contract
- BWX Technologies-led team awarded $30B contract from DOE/NNSA
- BWX Technologies price target lowered to $107 from $110 at Deutsche Bank
- BWX Technologies submits Drug Master File to FDA for Actinium-225 API